Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) Other Non Operating Income (2020 - 2025)

Historic Other Non Operating Income for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $82000.0.

  • NeuroPace's Other Non Operating Income fell 6255.71% to $82000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$572000.0, marking a year-over-year decrease of 18732.82%. This contributed to the annual value of $304000.0 for FY2024, which is 19650.79% up from last year.
  • Latest data reveals that NeuroPace reported Other Non Operating Income of $82000.0 as of Q3 2025, which was down 6255.71% from -$486000.0 recorded in Q2 2025.
  • Over the past 5 years, NeuroPace's Other Non Operating Income peaked at $265000.0 during Q4 2023, and registered a low of -$3.1 million during Q1 2021.
  • Its 5-year average for Other Non Operating Income is -$327105.3, with a median of -$82000.0 in 2025.
  • Examining YoY changes over the last 5 years, NeuroPace's Other Non Operating Income showed a top increase of 28150.68% in 2023 and a maximum decrease of 2713333.33% in 2023.
  • Quarter analysis of 5 years shows NeuroPace's Other Non Operating Income stood at -$2000.0 in 2021, then crashed by 7200.0% to -$146000.0 in 2022, then skyrocketed by 281.51% to $265000.0 in 2023, then plummeted by 132.45% to -$86000.0 in 2024, then surged by 195.35% to $82000.0 in 2025.
  • Its last three reported values are $82000.0 in Q3 2025, -$486000.0 for Q2 2025, and -$82000.0 during Q1 2025.